Healthcare AI in Baltimore: companies and research

Healthcare AI in Baltimore includes several different kinds of work: connecting patient data, analyzing images, supporting care, and developing research tools. Those categories should not be collapsed into a claim that every product is ready for clinical use.

The companies below have specific primary evidence for their AI work and a documented Baltimore connection. This is an ecosystem guide, not a recommendation to use a medical product.

Connected health and care support

b.well Connected Health offers conversational AI and care navigation from a Baltimore base. Its data-network milestone has independent corroboration: an August 5, 2026 CMS showcase describes the company’s CMS Aligned Network as live in production. Network operation does not establish clinical effectiveness for its AI features.

Welldoc is based in Columbia. Its AI Lab describes AI research and data science for cardiometabolic care, including collaboration with Johns Hopkins. Columbia is part of the regional picture, with its own location clearly identified.

Imaging, devices, and research tools

JuneBrain identifies Baltimore headquarters and a 2026 AI-powered retinal OCT analysis pilot. Its product notice says investigational use only, not clinical diagnosis. That limitation belongs beside the product description.

Sonavex describes EchoMap’s use of ultrasound and AI in dialysis-access visualization and announced its clearance in April 2025. The company’s announcement and current product page distinguish EchoMap from investigational EchoMark/EchoSure for AV-access use.

Infinite Biomedical Technologies is a Baltimore prosthetic-control business with Johns Hopkins roots and documented machine-learning work. Its Sense System appears on the FDA AI-enabled-device list. This does not establish that every current product in its catalog uses AI.

Two familiar names now belong to larger companies

PGDx became part of Labcorp in 2022. Labcorp’s current kitted-solutions page explicitly describes machine learning in its testing analysis.

Protenus was acquired by Bluesight in January 2025. Its patient-privacy solution was renamed PrivacyPro. Sources: acquisition and rebrand. We describe its Baltimore origins without asserting a current standalone local office.

Techstars is a route into the ecosystem

Techstars’ expanded anchor collaboration connects Johns Hopkins and CareFirst with UMMS, UMB, and MedStar. Its Spring 2026 announcement names eight participants: Amissa, Biolinco, Cerevanta, Citrus Oncology, Concordare Trials, Allumbra, Intelizen, and Percy. Cohort participation is not evidence of a Baltimore headquarters. Sources: Techstars collaboration announcement and Spring 2026 class.

The June 3, 2026 Demo Day is a past milestone, not an upcoming event. The Pava Center event archive records the program. For the next cycle, use the current accelerator page.

Questions to ask before a partnership

Identify the exact product, its intended user, its current research or regulatory status, and the evidence supporting its performance claims. Ask which organization owns the product today and what local team you would actually work with. Those details are more useful than a generic “Hopkins-affiliated” label.

Continue with the company directory, research resources, or fall AI events.